Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H5N3O |
Molecular Weight | 123.1127 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1=CN=CC=N1
InChI
InChIKey=IPEHBUMCGVEMRF-UHFFFAOYSA-N
InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)
Molecular Formula | C5H5N3O |
Molecular Weight | 123.1127 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:22:42 UTC 2023
by
admin
on
Fri Dec 15 15:22:42 UTC 2023
|
Record UNII |
2KNI5N06TI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-VATC |
QJ04AM05
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ISO/PYR/RIF)
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-ATC |
J04AM06
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-ATC |
J04AK01
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-ATC |
J04AM05
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4 (ETH/ISO/PYR/RIF)
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-VATC |
QJ04AM06
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
LIVERTOX |
NBK547856
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
NDF-RT |
N0000175483
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
WHO-VATC |
QJ04AK01
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
||
|
FDA ORPHAN DRUG |
6585
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID9021215
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
CHEMBL614
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
2328
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
Pyrazinamide
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
PYRAZINAMIDE
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
PYRAZINAMIDE
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless. Solubility: Sparingly soluble in water; slightly soluble in ethanol (~750 g/l) TS. Category: Antituberculosis drug. Storage: Pyrazinamide should be kept in a well-closed container. Definition: Pyrazinamide contains not less than 98.5% and not more than 101.0% of C5H5N3O, calculated with reference to the anhydrous substance. | ||
|
202-717-6
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
1046
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
SUB10163MIG
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
786
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
7287
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
D011718
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
3576
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
2KNI5N06TI
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
14911
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
45285
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
100000080846
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
DB00339
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
98-96-4
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
8987
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | RxNorm | ||
|
m9337
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | Merck Index | ||
|
1585006
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
2KNI5N06TI
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY | |||
|
C29395
Created by
admin on Fri Dec 15 15:22:42 UTC 2023 , Edited by admin on Fri Dec 15 15:22:42 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
MIC value of the in vitro growth of Mycobacterium Tuberculosis (H37RV strain) of the new anti-tuberculosis terpenoid derived agent tested was 20 ug/ml.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC |
|
||